GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Diagnostics AB (OSTO:IDLDX) » Definitions » Future Policy Benefits

IDL Diagnostics AB (OSTO:IDLDX) Future Policy Benefits


View and export this data going back to 2011. Start your Free Trial

What is IDL Diagnostics AB Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


IDL Diagnostics AB Business Description

Traded in Other Exchanges
Address
Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.